Eli Lilly And Co vs Energy Fuels Inc Ordinary Shares (Canada) — how do they compare? Eli Lilly And Co trades at $1,231.35 (market cap $1.08T), while Energy Fuels Inc Ordinary Shares (Canada) trades at $8.18 (market cap $2.21B). The key difference: Eli Lilly And Co is far larger — about 488.7× Energy Fuels Inc Ordinary Shares (Canada)'s market cap, and Eli Lilly And Co pays a 0.57% dividend while Energy Fuels Inc Ordinary Shares (Canada) pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 94 Days and Energy Fuels Inc Ordinary Shares (Canada) for 0 Days on average.
| LLY | UUUU | |
|---|---|---|
Market Cap | $1.08T | $2.21B |
Volume | 2,520,401 | 15,605,017 |
Sector | Health | Energy |
52-Week High | $1.28K | $27.72 |
52-Week Low | $799.57 | $8.34 |
Typical Hold Time | 94 Days | 0 Days |
Enterprise Value | $1.12T | $1.95B |
Dividend Yield | 0.57% | — |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,166.51, down 1.36% on the day, amid strong fundamentals with revenue surging to $65.18B in 2025 and net income reaching $20.64B. The stock exhibits a bullish technical trend, supported by moving averages, with key resistance near $1,190. Recent news highlights promising pipeline developments in weight-loss drugs, reinforcing growth prospects.
Outlook remains positive given robust earnings beats, high analyst buy ratings (73%), and a consensus price target of $1,350. Risks include competitive pressures and execution challenges in scaling production. The stock's premium valuation (P/E 39.16) warrants monitoring, but strong cash flow and innovation pipeline support long-term upside.
Energy Fuels (UUUU) trades at $9.27, down 4.04% amid negative sentiment following a securities fraud investigation announcement. The stock shows weak technical positioning near recent lows with neutral indicators. Fundamentally, the company continues to report significant losses with a -77.3% net income margin despite revenue growth projections, while heavy investment in uranium and rare earth expansion creates substantial cash burn.
While analyst consensus remains bullish with a $21.06 price target representing 127% upside, execution risks are elevated. The securities investigation, persistent losses, and massive capital requirements for growth projects create substantial headwinds. Success depends on the company's ability to fund expansion and achieve profitability in the competitive critical minerals sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →Energy Fuels Inc. is a US producer of uranium, vanadium, and rare earth elements. It operates the White Mesa Mill in Utah, the only fully licensed and operating conventional uranium processing facility in the country.
Read more on UUUU →